SEATTLE, WA--(Marketwire - April 04, 2008) - Pacific Biometrics, Inc. (OTCBB: PBME) today announced the signing of a series of contracts worth a combined $3.0 million with a major multinational Sponsor. The contracts relate to a series of clinical trials that form part of a global phase II and phase III program that is investigating the safety and efficacy of a follow-on biological approach for the treatment of rheumatoid arthritis.
